Rare Disease Research & Development Project ‘NADER’ to launch in partnership with Burjeel & BridgeBio Pharma
Abu Dhabi: Burjeel Holdings, one of the largest healthcare providers in the MENA region, and BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, have announced a new project to revolutionize the field of early diagnosis and treatment of rare diseases or disorders in the UAE and the region. The two […]
